S. Hallenberger

发表

Binding Kinetics of Darunavir to Human Immunodeficiency Virus Type 1 Protease Explain the Potent Antiviral Activity and High Genetic Barrier

K. Hertogs, Emmanuel Gustin, Johan Vandersmissen, 2007, Journal of Virology.

MAPPIT (MAmmalian Protein-Protein Interaction Trap) as a tool to study HIV reverse transcriptase dimerization in intact human cells.

I. Lemmens, J. Tavernier, S. Lievens, 2008, Journal of virological methods.

Resistance Mutations in Human Immunodeficiency Virus Type 1 Integrase Selected with Elvitegravir Confer Reduced Susceptibility to a Wide Range of Integrase Inhibitors

K. Hertogs, Peggy Geluykens, Inge Vereycken, 2008, Journal of Virology.

Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo.

J. Trappe, S. Goldmann, K. Henninger, 2001, Antiviral research.

The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs.

D. Bernstein, A. McGregor, M. Schleiss, 2005, Antiviral research.

T Cells + on IFN Signature in CD4 Anti-HIV State but Not Apoptosis Depends

Russell, R. Dummer, H. Joller, 2022 .

Anti-HIV State but Not Apoptosis Depends on IFN Signature in CD4+ T Cells

R. Dummer, H. Joller, H. Simon, 2006, The Journal of Immunology.

Susceptibilities of Human Cytomegalovirus Clinical Isolates to BAY38-4766, BAY43-9695, and Ganciclovir

G. Drusano, S. Hallenberger, J. McSharry, 2001, Antimicrobial Agents and Chemotherapy.

Processing and routage of HIV glycoproteins by furin to the cell surface.

H. Klenk, W. Garten, S. Hallenberger, 1999, Virus research.

Benzoxazole and benzothiazole amides as novel pharmacokinetic enhancers of HIV protease inhibitors.

T. Jonckers, J. Sasaki, M. Rouan, 2012, Bioorganic & medicinal chemistry letters.

Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action.

J. Trappe, J. Herrington, S. Goldmann, 2001, The Journal of antimicrobial chemotherapy.

A Novel Nonnucleoside Inhibitor Specifically Targets Cytomegalovirus DNA Maturation via the UL89 and UL56 Gene Products

H. Klenk, A. Popp, S. Hallenberger, 2001, Journal of Virology.

Development of robust antiviral assays for profiling compounds against a panel of positive-strand RNA viruses using ATP/luminescence readout.

K. Hertogs, E. Gong, T. Ivens, 2008, Journal of virological methods.

Antivirals against DNA viruses (hepatitis B and the herpes viruses).

H. Rübsamen-Waigmann, G. Hewlett, S. Hallenberger, 2004, Current opinion in pharmacology.

Original articles Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action

J. Trappe, J. Herrington, S. Goldmann, 2001 .

Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against “Nucleotide-competing Reverse Transcriptase Inhibitors”*

S. L. Le Grice, D. Jochmans, E. Tchesnokov, 2008, Journal of Biological Chemistry.

Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis

J. Tavernier, R. Clayton, D. Catteeuw, 2010, Retrovirology.

Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis

J. Tavernier, R. Clayton, D. Catteeuw, 2009, Nucleic acids research.

Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages.

R. Andreesen, A. Bouazzaoui, H. von Briesen, 2006, Virology.

Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60

H. Klenk, E. Shaw, W. Garten, 1992, Nature.

The role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cells

H. Klenk, M. Sordel, W. Garten, 1997, Journal of virology.

Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones.

H. Klenk, E. Shaw, W. Schäfer, 1994, Biochimie.

Secretion of a truncated form of the human immunodeficiency virus type 1 envelope glycoprotein.

R. Compans, S. Tucker, R. Owens, 1993, Virology.

Binding kinetics, uptake and intracellular accumulation of F105, an anti-gp120 human IgG1kappa monoclonal antibody, in HIV-1 infected cells.

K. Hertogs, R. Clayton, M. Van Loock, 2007, Journal of virological methods.